HSIC Henry Schein
- 73.310
- -0.130-0.18%
- 73.310
- 0.0000.00%
Henry Schein News
Henry Schein Price Target Raised to $92.00/Share From $90.00 by Barrington Research
Henry Schein Price Target Raised to $92.00/Share From $90.00 by Barrington Research
Henry Schein Is Maintained at Outperform by Barrington Research
Henry Schein Is Maintained at Outperform by Barrington Research
Barrington Research Maintains Outperform on Henry Schein, Raises Price Target to $92
Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperform and raises the price target from $90 to $92.
Lucas Systems Announces 100 Billion Warehouse Picks
Credits Continuous Innovation of Technologies Centered Around WorkersWEXFORD, Pa., May 8, 2024 /PRNewswire/ -- Warehouse workers made 100 billion warehouse picks using Lucas Systems software, accordi
UBS Adjusts Price Target on Henry Schein to $80 From $82, Maintains Neutral Rating
Henry Schein (HSIC) has an average hold rating and price target range of $65 to $90, according to analysts polled by Capital IQ. Price: 73.67, Change: +2.47, Percent Change: +3.46
Henry Schein Is Maintained at Neutral by UBS
Henry Schein Is Maintained at Neutral by UBS
Henry Schein Price Target Cut to $80.00/Share From $82.00 by UBS
Henry Schein Price Target Cut to $80.00/Share From $82.00 by UBS
UBS Maintains Neutral on Henry Schein, Lowers Price Target to $80
UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers the price target from $82 to $80.
Henry Schein Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 12.44% UBS $82 → $80 Maintains Neutral 03/06/2024 23.68% JP Morgan $82 → $88 Maintains Overweig
Analysts Have Conflicting Sentiments on These Healthcare Companies: Henry Schein (HSIC) and Esperion (ESPR)
Barrington Ups Price Target on Henry Schein to $92 From $90, Maintains Outperform Rating
Barrington Ups Price Target on Henry Schein to $92 From $90, Maintains Outperform Rating.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Henry Schein, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target price by $3
Goldman Sachs Adjusts Price Target on Henry Schein to $74 From $76
Henry Schein (HSIC) has an average rating of hold and price targets ranging from $65 to $90, according to analysts polled by Capital IQ.
Baird Adjusts Price Target on Henry Schein to $81 From $83, Maintains Neutral Rating
Henry Schein (HSIC) has an average rating of hold and price targets ranging from $65 to $90, according to analysts polled by Capital IQ.
Henry Schein Sell Rating Affirmed Amidst Cybersecurity Woes and Execution Risks
Earnings Call Summary | Henry Schein(HSIC.US) Q1 2024 Earnings Conference
The following is a summary of the Henry Schein, Inc. (HSIC) Q1 2024 Earnings Call Transcript:Financial Performance:Henry Schein reported Q1 global sales of $3.2 billion, up by 3.7%.Q1 GAAP net income
Henry Schein: Strong Q1 Earnings but Uncertain Outlook Warrants Hold Rating
Goldman Sachs Sticks to Their Hold Rating for Henry Schein (HSIC)
Henry Schein | 10-Q: Quarterly report
Dental Supplies Distributor Henry Schein's Tech Segment Provides Some Stability In Challenging Macro Times: Analyst
Tuesday, Henry Schein Inc (NASDAQ:HSIC) reported a first-quarter adjusted EPS of $1.10, down 9% Y/Y, beating the consensus of $1.01.Sales were $3.17 billion, an increase of 3.7% Y/Y, missing the conse
Analysis
Price Target
No Data
